Loading...
Loading...
India's levothyroxine imports from UNITED STATES total $551.1K across 220 shipments from 15 foreign suppliers. PAR STERILE PRODUCTS leads with $270.6K in import value; the top 5 suppliers together control 78.0% of this origin. Leading Indian buyers include PAR FORMULATIONS PRIVATE LIMITED. This corridor reflects India's pharmaceutical import demand for levothyroxine — a diversified sourcing base with multiple active suppliers from UNITED STATES.

PAR STERILE PRODUCTS is the leading Levothyroxine supplier from UNITED STATES to India, with import value of $270.6K across 10 shipments. The top 5 suppliers — PAR STERILE PRODUCTS, PAR STERILE PRODUCTS LLC, SPRING BIO SOLUTION, AGRACE PHARMA, ESPEE BIOPHARMA & FINECHEM LLC — collectively account for 78.0% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | PAR STERILE PRODUCTS | $270.6K | 10 | 49.1% |
| 2 | PAR STERILE PRODUCTS LLC | $66.2K | 2 | 12.0% |
| 3 | SPRING BIO SOLUTION | $38.5K | 7 | 7.0% |
| 4 | AGRACE PHARMA | $33.3K | 8 | 6.0% |
| 5 | ESPEE BIOPHARMA & FINECHEM LLC | $21.3K | 26 | 3.9% |
| 6 | RAFF & HALL PHARMACY | $18.2K | 13 | 3.3% |
| 7 | AMSTERDAM PHARMA (APTEKA RX INC) | $13.7K | 2 | 2.5% |
| 8 | SPECGX LLC | $12.5K | 4 | 2.3% |
| 9 | REGIONAL PHARMACY | $12.1K | 16 | 2.2% |
| 10 | SUN PHARMACEUTICAL INDUSTRIES INC. | $10.5K | 15 | 1.9% |
| 11 | GOOD HELTH PHARMA SUPPLIES | $8.3K | 4 | 1.5% |
| 12 | ASCENT PHARMACEUTICALS INC. | $7.4K | 12 | 1.3% |
| 13 | AMSTERDAM PHARMA (APTEKA RX INC.) | $7.3K | 15 | 1.3% |
| 14 | GREENE-VAN PHARMACY CORP | $3.3K | 6 | 0.6% |
| 15 | PHARMACEUTICAL BUYERS INTERNATIONAL | $3.3K | 3 | 0.6% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | PAR FORMULATIONS PRIVATE LIMITED | $336.7K | 12 | 61.1% |
| 2 | INTAS PHARMACEUTICALS LIMITED | $74.7K | 50 | 13.6% |
| 3 | STERISCIENCE SPECIALTIES PRIVATE LIMITED | $37.6K | 6 | 6.8% |
| 4 | HETERO LABS LIMITED | $21.6K | 6 | 3.9% |
| 5 | VEEDA CLINICAL RESEARCH LIMITED | $12.5K | 4 | 2.3% |
| 6 | SUN PHARMACEUTICAL INDUSTRIES LIMITED | $10.5K | 15 | 1.9% |
| 7 | MACLEODS PHARMACEUTICALS LTD | $8.0K | 4 | 1.4% |
| 8 | INTAS PHARMACEUTICALS LTD. | $6.2K | 1 | 1.1% |
| 9 | LAURUS LABS LIMITED | $6.0K | 15 | 1.1% |
| 10 | XYLOPIA LABS PRIVATE LIMITED | $5.0K | 8 | 0.9% |
| 11 | MANKIND PHARMA LIMITED | $4.3K | 9 | 0.8% |
| 12 | CLIANS LABS PRIVATE LIMITED | $3.8K | 8 | 0.7% |
| 13 | AZIDUS LABORATORIES LIMITED | $3.6K | 4 | 0.7% |
| 14 | AUROBINDO PHARMA LIMITED | $3.4K | 7 | 0.6% |
| 15 | UNITED STATES PHARMACOPEIA - INDIA PRIVATE LIMITED | $3.3K | 3 | 0.6% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Levothyroxine suppliers from UNITED STATES to India include PAR STERILE PRODUCTS, PAR STERILE PRODUCTS LLC, SPRING BIO SOLUTION. The leading supplier is PAR STERILE PRODUCTS with import value of $270.6K USD across 10 shipments. India imported Levothyroxine worth $551.1K USD from UNITED STATES in total across 220 shipments.
India imported Levothyroxine worth $551.1K USD from UNITED STATES across 220 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Levothyroxine sourced from UNITED STATES include PAR FORMULATIONS PRIVATE LIMITED, INTAS PHARMACEUTICALS LIMITED, STERISCIENCE SPECIALTIES PRIVATE LIMITED. The largest buyer is PAR FORMULATIONS PRIVATE LIMITED with $336.7K in imports across 12 shipments.
The total value of Levothyroxine imports from UNITED STATES to India is $551.1K USD, across 220 shipments and 15 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
220 Verified Shipments
15 suppliers, 15 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists